Monkeypox virus
(enveloped virus)

Enveloped viruses
These viruses have glycoproteins on their envelope, which are potential targets for external influences.

Update: Since 28.11.2022, the WHO recommends using the term mpox for the disease "monkeypox". A new name for the monkeypox virus is currently being developed by the International Committee on the Taxonomy of Viruses (ICTV).

The Monkeypox virus (Orthopoxvirus simiae) is an enveloped virus of the Poxviridae family.

First symptoms of a mpox infection are flu-like: fever, headache, muscle aches and asthenia. As the disease progresses, typical skin lesions develop, often affecting the face and palms. However, other areas of the body, such as the urogenital area, can also be affected.

Monkeypox virus is mainly transmitted from animals to humans, e.g. through contact with secretions and excretions from infected animals. Rodents are the possible reservoir. However, transmission from human to human is also possible in the case of close contact with infected persons. This mainly includes contact with virus-containing material such as body fluids or skin crusts of infected persons.

Monkeypox infections occur mainly in West and Central Africa. Since the beginning of the 2000s, isolated infections with the virus have also been reported outside the African continent. In May 2022, increased cases of mpox were reported in North America and Europe, including Germany. Persons without a respective travel history (West and Central Africa) were also affected.

»Necessary spectrum of antimicrobial activity:

Virucidal acitivity against enveloped viruses

Click here to find products with activity against enveloped viruses

This might also interest you